Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism IRF5 inhibitors(interferon regulatory factor 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Systemic Lupus Erythematosus | Preclinical | US | 16 Nov 2020 |